2018 State of the Heart
Welcome to the 2018 State of the Heart, the UK Gill Heart & Vascular Institute annual report.
We at Gill are extremely proud to be leading the fight against cardiovascular disease Kentucky, where these problems plague many of our communities.
Our expert team includes physicians and scientists who draw from disciplines of cardiovascular medicine, cardiac and vascular surgery, radiology, anesthesiology, pharmacy, physiology, pharmacology, biomedical engineering, and more. We are well on our way to becoming a fully integrated service line with constant collaboration/communication between cardiology, vascular, and CT. This multidisciplinary approach facilitates more effective patient care, better outcomes and new and better discoveries.
As the region’s top teaching and research center, supported by the NIH-funded UK Center for Clinical and Translational Science, our bench-to-bedside approach ensures that patients benefit from scientific advances nearly as fast as they happen.
The 2018 State of the Heart highlights our services and showcases some of our accomplishments of the past year, all of which are a demonstration of our commitment to improving the future of heart health in Kentucky and beyond.
We invite you to take a look.
UK researchers receive prestigious grant to investigate vascular disease. Read about this award from the American Heart Association.
The Cardiovascular Genetics and Precision Medicine Program at the UK Gill Heart & Vascular Institute specializes in the diagnosis and treatment of hereditary cardiovascular diseases, and in researching new approaches to preventing and treating those diseases.
Virtual Heart Could Lead to Better Long-Term Outcomes. Read about Jonathan Wenk and Kenneth Campbells' project.
Advancements in Clinical Care
The UK Gill Heart & Vascular Institute is one of only five facilities in Kentucky to offer the WATCHMAN implant. Read more about this procedure.
Currently, UK is the only medical center in Kentucky to provide an adult ECMO transport service. Read more about our ECMO transport team.
The contribution of excellent imaging to the patient’s outcome is often overlooked, but the right test at the right time can make all the difference. Read about UK Cardiac Imaging.
Experimental heart valve turns life around for Manchester woman. Read Priscilla's story.
The UK Gill Heart & Vascular Institute has taken a lead role regionally in a national study that has shown when EMS and hospitals use a standardized procedure. Find out how this can help heart attack patients.
In 2017, the UK Cardiac Surgery team performed more than 700 cardiac surgical procedures, more impressive than this record number, however, was the observed-to-expected mortality ratio of 0.66. Read about our quality initiatives.
In 2017, the UK Transplant Center performed its 400th heart transplant, marking a major milestone for a heart transplant program. Read more about this milestone.
The Gill Heart & Vascular Institute is delving into two cutting-edge technologies that have the potential to provide a better quality of life for a population of advanced heart failure patients. Read about this study.
The UK Gill Heart & Vascular Institute provides the region’s only expertise in the management of pulmonary hypertension. Learn more about our team.
It’s no secret that Supervised Exercise Training benefits patients who present with symptoms of PAD, or peripheral artery disease.
UK Vascular & Endovascular Surgery is dedicated to treating all aspects of vascular disease for the people of Kentucky and surrounding areas. Click here for more data.
Whitney Stevenson knew she was atypical for heart disease, but she also knew something was physically wrong despite what doctors were telling her. Read Whitney's story.